Neuren Pharmaceuticals announced that its US listed partner, Acadia Pharmaceuticals, will seek a re-examination of the ...
Magellan Financial Group’s shares surged after emerging from its trading halt for its completed $130 million institutional placement as part of its proposal to merge with Barrenjoey Capital Partners.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results